Connections between type II DM and cardiovascular diseases
Keywords:
type II diabetes, cardiovascular diseasesAbstract
DM and cardiovascular pathologies are severe conditions, which have at their etiological and pathogenic basis a series of common factors that act in a complex manner. The recent study aimed to study clinical-paraclinical aspects of patients with DM type II associated with cardiovascular pathologies. According to the data obtained, most of the patients included in the study were over 60 years old, with a history of type II DM lasting more than 10 years, with the predominance of decompensated type II DM, with severe cardiovascular complications: acute coronary syndrome, arterial hipertension, sustained stroke, atrial fibrillation, atrial flutter, supraventricular tachycardia, LAD stenosis, ventricular extrasystole, diabetic retinopathy, diabetic nephropathy, distal symmetric sensitive diabetic polyneuropathy. Both cardiovascular disease and DM can and should be prevented by controlling predisposing risk factors. Changing lifestyle habits (preventing or treating obesity, promoting physical activity, healthy eating, excluding smoking, reducing or remodeling the attitude towards chronic stress) is at the heart of the public health strategy for the prevention of cardiovascular diseases and DM.
References
1. International Diabetes Federation. IDF Diabetes Atlas - 8th Edition. http://diabete satlas.org/resources/2017-atlas.html (June 14 2019)
2. Al-Nozha, M. M., Ismail, H. M., & Al Nozha, O. M. (2016). Coronary artery disease and diabetes mellitus. Journal of Taibah University Medical Sciences,2016; 11(4), 330-338. https://doi.org/10.1016/j.jtumed.2016.03.005
3. Chaurasia B, Summers SA. Ceramides - lipotoxic inducers of metabolic disorders. Trends Endocrinol Metab. 2015;26(10):538-50. https://doi.org/10.1016/j.tem.2015.07.006
4. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375-84. https://doi.org/10.1056/NEJMoa1211585
5. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/ SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):2564603. https://doi.org/10.1016/j.jacc.2012.07.013
6. Kartha CC, Pillai Radhakrishna M, Ramachandran S.-Mechanisms of Vascular Defects in Diabetes Mellitus -08.03.2017 https://doi.org/10.1007/978-3-319-60324-7
7. Martín-Timón, I. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World Journal of Diabetes, 2014;5(4), 444. https://doi.org/10.4239/wjd.v5.i4.444
8. Mueller C. Biomarkers and acute coronary syndromes: an update. Eur Heart J. 2014;35:552-6. 9. Paneni, Francesco & Cosentino, Francesco. Diabetes and Cardiovascular Disease: A Guide to Clinical Management.201510.
10. Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021; 12(4): 383-406. https://doi.org/10.4239/wjd.v12.i4.383
11. Scott M. Grundy AM., et al. Diabetes and Cardiovascular Disease. A Statement for Healthcare Professionals From the American Heart. Circulation. 1999;100:1134-1146 https://doi.org/10.1161/01.CIR.100.10.1134
12. Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. Philadelphia, Pa: WB Saunders Co; 1998:973-1059.
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
